Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) EPS (Basic) (2021 - 2025)

Historic EPS (Basic) for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $2.74.

  • Krystal Biotech's EPS (Basic) rose 18842.11% to $2.74 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9, marking a year-over-year increase of 27500.0%. This contributed to the annual value of $3.12 for FY2024, which is 67958.0% up from last year.
  • Per Krystal Biotech's latest filing, its EPS (Basic) stood at $2.74 for Q3 2025, which was up 18842.11% from $1.33 recorded in Q2 2025.
  • Krystal Biotech's EPS (Basic)'s 5-year high stood at $2.88 during Q3 2023, with a 5-year trough of -$1.99 in Q1 2022.
  • For the 5-year period, Krystal Biotech's EPS (Basic) averaged around -$0.0, with its median value being -$0.7 (2021).
  • As far as peak fluctuations go, Krystal Biotech's EPS (Basic) crashed by 16885.03% in 2022, and later soared by 403333.33% in 2025.
  • Over the past 5 years, Krystal Biotech's EPS (Basic) (Quarter) stood at -$0.95 in 2021, then tumbled by 31.58% to -$1.25 in 2022, then skyrocketed by 125.6% to $0.32 in 2023, then surged by 397.44% to $1.59 in 2024, then surged by 72.13% to $2.74 in 2025.
  • Its EPS (Basic) stands at $2.74 for Q3 2025, versus $1.33 for Q2 2025 and $1.24 for Q1 2025.